webinar register page

*second showing* Update from Avadel on investigational clinical treatment
This is the second showing of a previously recorded webinar where Avadel explains the recent FDA tentative approval of LUMRYZ™ (sodium oxybate) for extended-release oral suspension, an investigational narcolepsy clinical treatment (formerly known as FT218), and addresses questions from the narcolepsy community that were submitted in advance of the original webinar on August 10.

Sep 13, 2022 08:00 PM in Eastern Time (US and Canada)

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Narcolepsy Network.